Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 EUR | +7.43% | +55.77% | -8.99% |
May. 24 | Beewize on top; Bioera on the bottom | AN |
May. 23 | Exprivia on top; down Bioera | AN |
Sales 2021 | 24.18M 26.22M | Sales 2022 | 24.66M 26.75M | Capitalization | 7.7M 8.35M |
---|---|---|---|---|---|
Net income 2021 | -3M -3.25M | Net income 2022 | 5M 5.42M | EV / Sales 2021 | 0.76 x |
Net Debt 2021 | 8.7M 9.43M | Net Debt 2022 | 3.39M 3.68M | EV / Sales 2022 | 0.45 x |
P/E ratio 2021 |
-3.05
x | P/E ratio 2022 |
1.75
x | Employees | 194 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 75.81% |
1 day | +7.43% | ||
1 week | +55.77% | ||
Current month | +71.97% | ||
1 month | +70.89% | ||
3 months | +125.00% | ||
6 months | -33.33% | ||
Current year | -8.99% |
Managers | Title | Age | Since |
---|---|---|---|
Secondo Dentis
DFI | Director of Finance/CFO | 79 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Luigi Maniglio
CHM | Chairman | 62 | 20-12-31 |
Marco Livelli
BRD | Director/Board Member | 65 | - |
Laura Morgagni
BRD | Director/Board Member | 50 | 17-07-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.81 | +7.43% | 2,268,987 |
24-05-23 | 0.754 | +12.54% | 2,188,699 |
24-05-22 | 0.67 | +19.22% | 1,501,402 |
24-05-21 | 0.562 | +9.34% | 933,538 |
24-05-20 | 0.514 | -1.15% | 697,198 |
Real-time Borsa Italiana, May 24, 2024 at 11:44 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.99% | 27.34M | |
-9.93% | 13.63B | |
+2.06% | 5.09B | |
+28.62% | 5.08B | |
-4.06% | 5.01B | |
+14.85% | 4.4B | |
-21.09% | 4.34B | |
+9.60% | 3.78B | |
+40.31% | 3.74B | |
-2.53% | 3.21B |
- Stock Market
- Equities
- FDA Stock